Greenwich LifeSciences (GLSI)
NASDAQ:GLSI
US Market
Holding GLSI?
Track your performance easily

Greenwich LifeSciences (GLSI) Financial Statements

361 Followers

Greenwich LifeSciences Financial Overview

Greenwich LifeSciences's market cap is currently ―. The company's EPS TTM is $-0.794; its P/E ratio is -18.75; Greenwich LifeSciences is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -2.61M$ -2.47M$ -2.75M$ -2.39M$ -1.63M
EBITDA$ -2.61M$ -2.47M$ -2.75M$ -2.39M$ -1.63M
Net Income Common Stockholders$ -2.61M$ -2.47M$ -2.75M$ -2.39M$ -1.63M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 7.22M$ 5.51M$ 6.99M$ 9.14M$ 10.94M
Total Assets$ 7.23M$ 5.51M$ 6.99M$ 9.15M$ 10.95M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -7.22M$ -5.51M$ -6.99M$ -9.14M$ -10.94M
Total Liabilities$ 1.35M$ 389.61K$ 294.41K$ 297.29K$ 301.55K
Stockholders Equity$ 5.88M$ 5.12M$ 6.70M$ 8.85M$ 10.65M
Cash Flow-
Free Cash Flow$ -1.05M$ -1.78M$ -2.15M$ -1.80M$ -966.98K
Operating Cash Flow$ -1.05M$ -1.78M$ -2.15M$ -1.80M$ -966.98K
Investing Cash Flow-----
Financing Cash Flow$ 2.77M$ 299.12K---
Currency in USD

Greenwich LifeSciences Earnings and Revenue History

Greenwich LifeSciences Debt to Assets

Greenwich LifeSciences Cash Flow

Greenwich LifeSciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis